Ear Infection Treatment — Cost, Top Hospitals & Success Rates | MyMedicPlus

Ear infections are among the most frequently encountered conditions in primary care and ENT practice, encompassing several distinct pathological entities with different microbiology, clinical presentation, and management principles. Otitis media (infection or inflammation of the middle ear) and otitis externa (infection of the outer ear canal) represent the two most common forms. Correct classification by clinical examination is essential, as treatment differs significantly between these entities.

Acute otitis media (AOM) typically follows viral upper respiratory tract infections that impair Eustachian tube function, allowing nasopharyngeal bacteria — predominantly Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis — to colonise the middle ear cavity. The condition presents with ear pain, fever, and hearing loss, and may evolve to spontaneous tympanic membrane perforation with otorrhoea. Management follows an evidence-based watchful waiting protocol for children over two years with mild disease, with antibiotic treatment (amoxicillin first-line) reserved for severe symptoms, under-twos, bilateral disease, and persistent cases.

Otitis externa involves infection of the external ear canal skin, commonly caused by Pseudomonas aeruginosa or Staphylococcus aureus following water exposure, mechanical trauma, or skin conditions such as eczema. Treatment centres on aural toilet (cleaning by an ENT clinician), topical acidifying agents, and antibiotic-corticosteroid ear drops. Chronic and recurrent ear disease — including otitis media with effusion, chronic suppurative otitis media, and cholesteatoma — requires specialist ENT management and frequently surgical intervention.

Acute otitis media is the primary indication for antibiotic treatment in ear infections, with amoxicillin-clavulanate for beta-lactamase-producing organisms and macrolides for penicillin-allergic patients. Otitis media with effusion (OME, glue ear) — non-infective middle ear fluid causing conductive hearing loss in children — is the primary surgical indication for grommet insertion when persistent for over three months with documented hearing loss. Recurrent AOM (five or more episodes per year) in children is an indication for prophylactic grommet insertion to prevent recurrence and associated hearing loss.

Otitis externa is managed with aural toilet and topical antibiotic ear drops; necrotising (malignant) otitis externa in diabetic or immunocompromised patients requires IV antipseudomonal antibiotics and urgent ENT management. Chronic suppurative otitis media (CSOM) with persistent discharge through a perforated eardrum requires topical antibiotic ear drops, aural microsuction, and hearing assessment, with tympanoplasty (eardrum repair) performed once the ear is dry. Cholesteatoma — destructive epithelial cyst in the middle ear — requires surgical mastoidectomy to prevent progressive ossicular, cochlear, facial nerve, and intracranial damage. Mastoiditis complicating AOM requires intravenous antibiotics, cortical mastoidectomy in non-responsive cases, and drainage of any subperiosteal abscess.

Medical treatment of acute ear infections is appropriate for all patients presenting with AOM or otitis externa regardless of age or health status. Watchful waiting without immediate antibiotics is appropriate for children over two years with mild AOM; immediate antibiotic treatment is indicated for children under two, bilateral AOM, severe symptoms (temperature over 39°C, significant pain), perforation with discharge, or clinical deterioration within 72 hours of watchful waiting.

Surgical management with grommet insertion is indicated for children with bilateral OME causing documented hearing loss of 25 dB or greater for three or more months. Children with Down syndrome, cleft palate, craniofacial syndromes, and immunodeficiency have higher rates of recurrent ear disease and warrant earlier surgical consideration. Adults with CSOM and persistent conductive hearing loss on audiometry are candidates for tympanoplasty once the ear is infection-free for at least three months. Cholesteatoma requires surgical intervention in virtually all cases given its destructive natural history. Contraindications to ear surgery include active infection requiring treatment first, systemic medical conditions precluding general anaesthesia, and significant uncontrolled bleeding disorders.

Medical management of AOM uses amoxicillin 40–90 mg/kg/day in divided doses for five to seven days in children and five days in adults as first-line therapy. Amoxicillin-clavulanate is used for treatment failures or when beta-lactamase-producing organisms are suspected. Adequate analgesia with paracetamol and ibuprofen is essential from the outset. For otitis externa, clinical aural toilet to remove debris is the critical first step; ciprofloxacin or neomycin-polymyxin-hydrocortisone ear drops twice daily for seven days achieve resolution in most cases. An ear wick (expandable sponge) may be placed in very oedematous canals to facilitate drop penetration.

Grommet (ventilation tube) insertion involves myringotomy (eardrum incision) and placement of a small plastic tube to ventilate the middle ear. Standard grommets remain for six to eighteen months before spontaneous extrusion; T-tubes are used for recurrent cases and remain for two to four years. Tympanoplasty repairs a perforated eardrum using a graft of temporalis fascia, tragal cartilage, or fat and restores the sound-conducting mechanism. Cortical mastoidectomy removes infected mastoid air cells in mastoiditis not responding to IV antibiotics. Combined approach tympanoplasty with mastoidectomy (canal wall up) or canal wall down mastoidectomy treats cholesteatoma, aiming for a disease-free, safe ear. Ossiculoplasty with titanium or cartilage prostheses reconstructs damaged hearing ossicles to restore conductive hearing.

Appropriate antibiotic treatment of AOM achieves symptom resolution within 48–72 hours in 80–90% of cases. Watchful waiting in mild-moderate AOM avoids unnecessary antibiotic use while achieving equivalent outcomes in most children over two years, with only 10–20% requiring antibiotics at 72 hours. Grommet insertion provides immediate hearing improvement — average audiological gain of 12–18 dB — in children with OME, with significant benefits for speech and language development. School performance improvements following resolution of glue ear-related hearing loss are consistently reported by parents and teachers.

Topical antibiotic ear drops achieve resolution of otitis externa within seven to ten days in 85–95% of cases. Tympanoplasty achieves successful eardrum closure in 85–90% of cases in experienced hands, eliminating water precautions and recurring discharge while improving conductive hearing. Mastoidectomy for cholesteatoma creates a safe, dry ear in 80–90% of cases, preventing progression to life-threatening intracranial complications. Ossiculoplasty restores useful hearing in approximately 70–80% of cases, typically achieving 20–30 dB hearing improvement.

Antibiotic treatment carries risks of gastrointestinal side effects (5–10% of patients), antibiotic allergy, and Clostridioides difficile colitis with broad-spectrum agents. Inadequately treated AOM may progress to acute mastoiditis (1–2% of untreated cases), meningitis, epidural abscess, sigmoid sinus thrombophlebitis, or facial nerve palsy — all requiring urgent hospitalisation and specialist care.

Grommet insertion risks include post-operative otorrhoea (discharge) in 16% of cases, grommet blockage (5%), tympanosclerosis (white patches on the eardrum, cosmetic only, 30–50%), and persistent perforation after extrusion (1–2%). Tympanoplasty carries a graft failure rate of 10–15% overall, with higher rates in chronically infected or revision ears. Mastoidectomy risks include facial nerve injury (<1% in experienced hands), sensorineural hearing loss, vertigo, meningitis, and cerebrospinal fluid leak. Otitis externa can progress to necrotising (malignant) otitis externa in diabetic or immunocompromised patients — a skull base osteomyelitis with high morbidity requiring prolonged IV antipseudomonal antibiotics and possible surgical debridement.

Medical treatment for acute AOM should be reviewed at 48–72 hours if symptoms do not improve, and at two weeks for young children to confirm resolution. Post-grommet children are reviewed at four to six weeks with pure-tone audiometry, then six-monthly until grommet extrusion and normal hearing are confirmed. During the grommet period, surface swimming is generally safe in clean water; deep diving and prolonged submersion should be avoided without custom earplugs.

Post-mastoidectomy follow-up involves wound review at one week, audiometry at six weeks, and CT scanning at six months to assess for residual or recurrent cholesteatoma. Canal wall down mastoidectomy cavities require regular cleaning by an ENT nurse every six months to prevent debris accumulation and recurrent infection. Tympanoplasty patients are reviewed at six weeks, three months, and twelve months with audiometry to assess graft integrity and hearing outcome. All patients with ear surgery should carry information about the procedure for any future medical care that might affect the ear (diathermy near the head, anaesthetic concerns).

Medical management of acute ear infections is low cost: primary care consultation and generic antibiotic prescription costs $20–$150 in most settings. Specialist ENT consultation costs $200–$500 in the US. Grommet insertion surgery in the US costs $2,000–$6,000 as a day procedure; in the UK, NHS waiting times can be 12–18 months with private grommet surgery costing £1,800–£3,500. Mastoidectomy with tympanoplasty for cholesteatoma in the US costs $15,000–$35,000.

International patients can access specialist ENT surgery at accredited centres in India, Thailand, and Malaysia at 60–75% lower cost. Grommet surgery in India costs $500–$1,200; mastoidectomy with tympanoplasty costs $3,000–$7,000 at centres such as Apollo, Fortis, and Medanta — compared to $15,000–$35,000 in the US. Thailand (Bumrungrad International), Malaysia (Gleneagles), and Singapore (National University Hospital) offer comparable quality with shorter waiting times at 40–65% lower cost than Western countries. The brief procedure and short hospital stay make ear surgery among the most practical treatments for medical tourism.

For acute otitis media in children over two years with mild symptoms, watchful waiting for 72 hours with analgesics and reassurance is the guideline-endorsed alternative to immediate antibiotic prescription. This approach avoids antibiotic side effects and resistance in the majority of cases that resolve spontaneously. For chronic middle ear effusion (glue ear), autoinflation using nasal balloon devices (Otovent) helps Eustachian tube function and has modest evidence for resolution of effusion in cooperative children aged over four years. Hearing aids are a non-surgical alternative to grommets for managing the hearing loss of OME without addressing underlying pathology.

For otitis externa, acetic acid (2% aqueous vinegar) ear drops used three to four times daily are as effective as topical antibiotic drops for mild-moderate infections while avoiding antibiotic resistance. For CSOM without cholesteatoma, intensive medical management with regular aural toilet, topical ciprofloxacin drops, and water precautions may maintain a dry safe ear without tympanoplasty in patients who are unfit for surgery or decline the procedure. Cholesteatoma has no effective non-surgical alternative — all cases require surgery to prevent progressive destruction of the middle and inner ear structures.